Abstract
Short interfering RNAs, or siRNAs, belong to a class of RNA species which play a role in both cellular defence and gene regulation. siRNAs are members of a larger RNA interference pathway found within cells and are involved in the degradation of RNAs which possess complementarity to specific target sequences. This property has given siRNA technology the potential to become a powerful new tool for a wide variety of disciplines, ranging from the design of novel anti-cancer agents to agricultural applications. The following review outlines novel delivery systems that can be used for applied siRNA technologies. Improved delivery systems for the cellular uptake of siRNAs using both viral expression vectors and nanoliposomal particles are discussed. New therapeutics that can be used to combat human disease and agricultural applications of siRNA technologies are also described. This review attempts to pave the way for future innovations based upon RNA interference in medicine and agriculture.
Keywords: siRNA, nanocarrier, lentiviral vector, delivery vehicle, RNA interference, siRNA Conjugates, virus expression vectors, Nonviral Nanocarrier Systems, VEGFR, neurodegenerative diseases
Drug Delivery Letters
Title: Delivery Systems for Applications in siRNA Technology
Volume: 1 Issue: 2
Author(s): Kathleen L. Hefferon
Affiliation:
Keywords: siRNA, nanocarrier, lentiviral vector, delivery vehicle, RNA interference, siRNA Conjugates, virus expression vectors, Nonviral Nanocarrier Systems, VEGFR, neurodegenerative diseases
Abstract: Short interfering RNAs, or siRNAs, belong to a class of RNA species which play a role in both cellular defence and gene regulation. siRNAs are members of a larger RNA interference pathway found within cells and are involved in the degradation of RNAs which possess complementarity to specific target sequences. This property has given siRNA technology the potential to become a powerful new tool for a wide variety of disciplines, ranging from the design of novel anti-cancer agents to agricultural applications. The following review outlines novel delivery systems that can be used for applied siRNA technologies. Improved delivery systems for the cellular uptake of siRNAs using both viral expression vectors and nanoliposomal particles are discussed. New therapeutics that can be used to combat human disease and agricultural applications of siRNA technologies are also described. This review attempts to pave the way for future innovations based upon RNA interference in medicine and agriculture.
Export Options
About this article
Cite this article as:
L. Hefferon Kathleen, Delivery Systems for Applications in siRNA Technology, Drug Delivery Letters 2011; 1 (2) . https://dx.doi.org/10.2174/2210304x11101020118
DOI https://dx.doi.org/10.2174/2210304x11101020118 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Innate Immunity and Intracellular Trafficking: Insights for Novel Anti- HIV-1 Therapeutics
Current Pharmacogenomics Hallucinations and Delusions in Children and Adolescents
Current Psychiatry Reviews Benzo[a]pyrene Toxicity and Inflammatory Disease
Current Rheumatology Reviews The Role of Inflammation in Epilepsy
Current Pediatric Reviews Update on ICOS: A Possible Target for Turning-Off Autoimmunity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Recent Patents on Nucleic Acid-Based Antiviral Therapeutics
Recent Patents on Anti-Infective Drug Discovery Treatment of Central Nervous System Tuberculosis Infections and Neurological Complications of Tuberculosis Treatment
Current Pharmaceutical Design Central Nervous System Disorders Associated to Immune Checkpoint Inhibitors
Current Cancer Therapy Reviews Acute Symptomatic Seizures in Geriatric Patients with Multiple Risk Factors - A Diagnostic Challenge
Current Aging Science Small Ruminant Lentiviruses and Human Immunodeficiency Virus: Cousins that Take a Long View
Current HIV Research Atopic Dermatitis and Cytokines: The Immunoregulatory and Therapeutic Implications of Cytokines in Atopic Dermatitis - Part II: Negative Regulation and Cytokine Therapy in Atopic Dermatitis
Recent Patents on Inflammation & Allergy Drug Discovery Monocytes Mediate HIV Neuropathogenesis: Mechanisms that Contribute to HIV Associated Neurocognitive Disorders
Current HIV Research Advancement in Nanoparticle-based Biosensors for Point-of-care <i>In vitro</i> Diagnostics
Current Topics in Medicinal Chemistry Necroptosis: Who Knew There were so Many Interesting Ways to Die?
CNS & Neurological Disorders - Drug Targets Meningococcal Disease and Future Drug Targets
CNS & Neurological Disorders - Drug Targets Domestic Arthropods and Their Allergens
Protein & Peptide Letters Chemical Constituents and Biological Activity of Chinese Medicinal Herb ‘Xihuangcao’
Combinatorial Chemistry & High Throughput Screening Cellular Reservoirs of HIV-1 and their Role in Viral Persistence
Current HIV Research New Opportunities in the Structure-based Design of Anti-Protozoan Agents
Current Topics in Medicinal Chemistry Enigmas and Paradoxes: the Genetic Diversity and Prevalence of the Primate Lentiviruses
Current HIV Research